December, 14
Cell & Gene Therapy Talks
10:00-10:30 (CET) Words of Welcome:
- Dr. Claudia Luther, BIOPRO Baden-Württemberg
- Michael Kleiner, Head of Department of the Baden-Württemberg Ministry of Economic Affairs, Labour and Tourism
- Rachel Scott, Department for International Trade
- Introduction to the ecosystems:
“Cell and gene therapy ecosystem in Baden-Württemberg”
Caroline Ref, BIOPRO Baden-Württemberg
- “From London to UK Advanced Therapies”
Dr. Francesca Gliubich, Director UK Advanced Therapies, King’s College London
10:30 (CET) Keynote: “Overcoming challenges in cell and gene therapies to accelerate the ATMP industry for the benefit of patients”
- Dr. John Kelly, Cell and Gene Therapy Catapult, Head of Transactions and International Business Development
10:50 (CET) Keynote: "Bringing next generation AAV gene therapies to the patients"
- Dr. François du Plessis, Boehringer Ingelheim Pharma, Research Beyond Borders, Scientific Expert
11:15 (CET) "Resolution Therapeutics: Cutting-edge cell therapies for advanced liver disease – from academia to the commercial space"
- Dr. Lara Campana, Resolution Therapeutics Ltd., VP, Macrophage Biology and co-founder
11:30 (CET) Keynote: “Prospects and challenges of clinical genome editing”
- Prof. Dr. Toni Cathomen, Institute for Transfusion Medicine & Gene Therapy, Director, Medical Center - University of Freiburg
11:55 (CET) "AaviGen - curing broken hearts with next-generation gene therapies"
- Prof. Dr. Patrick Most, AaviGen GmbH, CEO
12:15-01:00 (CET) Short Presentation Session
- Dr. Carina Rohmer - Fraunhofer IGB
- Isil Mirzanli - Manchester University NHS Foundation Trust
- George Frodsham - Medisieve
- Teresina Pinnington - NHS Blood & Transplant
- Astrid Kritzinger - Ulm University, Department of Gene Therapy
- Justin S Anthony - Universitätsklinikum Tübingen
Moderation:
Dr. Claudia Luther, Caroline Ref, BIOPRO Baden-Württemberg
Finn Willingham, Cell and Gene Therapy Catapult
01:40-05:00 CET | One-to-one Meetings
Book your individual 20-minutes meetings with other participants: make new contacts, exchange on the topic, find cooperation partners for R&D projects or business partners.
December, 15
Cell & Gene Therapy Talks
10:00 (CET) Words of Welcome
- Caroline Ref, BIOPRO Baden-Württemberg
10:10 (CET) “Antisense oligonucleotides for the treatment of the rare diseases Neurofibromatosis type 1 and muscular dystrophies”
- Prof. Linda Popplewell, Professor of Genetic Medicine, National Horizons Centre, Teesside University
10:25 (CET) "Organ-on-chip systems as new translational models for the assessment of cell and gene therapies"
- Prof. Peter Loskill, Head of Department for Microphysiological Systems, Eberhard Karls University Tübingen & NMI Natural and Medical Sciences Institute
10:45 (CET) “Modular mini-factories for the automated and scalable production of ATMP´s or small batches“
- Andreas Traube, Fraunhofer Institute for Manufacturing Engineering and Automation IPA, Head of Department of Laboratory Automation and Bioproduction Technology
11:00 (CET) “Specialities and best practices in clinical studies for cell & gene therapies”
- Prof. Fiona Thistlethwaite, The Christie and University of Manchester, iMATCH, director
11:25 (CET) "Making gene therapy medicines"
Prof. Bobby Gaspar, Orchard Therapeutics, CEO ; Hon. Professor University College London
11:45 (CET) "Cell Orchestration Solutions from TrakCel"
- Kamar Johnson, TrakCel, Business Development Director
12:00-01:00 (CET) Short Presentation Session
- Matthew Freer - Alcyomics
- Mohammad Rasty - BioHeart
- Iana Tarakanchikova - CapCo Bio GmbH
- Prof. Michael Schmitt - Heidelberg University Hospital
- Lena Schober - KyooBe Tech
- Antoine Espinet - MicrofluidX
- Katja Betts - Progen Biotechnik
Moderation:
Caroline Ref, BIOPRO Baden-Württemberg
01:40-05:00 CET | One-to-one Meetings
Book your individual 20-minutes meetings with other participants: make new contacts, exchange on the topic, find cooperation partners for R&D projects or business partners.
